CDKN1A and prostate carcinoma: In addition, apigenin has been shown to induce WAF1/p21 levels, resulting in G1 phase cell cycle arrest in androgen-responsive (LNCaP) and androgen-refractory (DU145) human prostate cancer cells [84,85].